Drug Profile
Research programme: neurological disorder therapeutics - AlzProtect
Alternative Names: AZP 13005; AZP 7015Latest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator AlzProtect
- Class Neuroprotectants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders
Most Recent Events
- 28 Sep 2021 No recent reports of development identified for research development in Neurological-disorders in France
- 07 Aug 2017 Early research in Neurological disorders in France before August 2017 (AlzProtect pipeline, August 2017)